Riskpilot← Back to searchSign inGet full accessEyeVision Oy
OYActiveY-tunnus 2566191-3Rauhalantie 4-B105Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20133 employees
Revenue 2025
EUR 981K
+6% vs 2024
EBITDA margin
1.5%
-48% vs 2024
Equity ratio
15.6%
Financial strength
Net profit 2025
EUR -4K
-129% vs 2024
| Revenue | EUR 981K | +6% |
| EBITDA | EUR 15K | -48% |
| Net profit | EUR -4K | -129% |
| Total assets | EUR 335K | +2% |
| Equity | EUR 52K | -8% |
| Employees | 3 | — |
Legal name
EyeVision Oy
Y-tunnus number
2566191-3
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. elokuuta 2013
Share capital
EUR 2 500
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on optisten, lääketieteellisten, eläinlääketieteellisten ja audiovisuaalisten laitteiden, kojeiden, tarvikkeiden, kalusteiden ja järjestelmien maahantuonti, vienti, myynti, markkinointi, edustus, suunnittelu, vuokraus, huolto, tukku- ja välitystoiminta, sekä kaikki muu laillinen liiketoiminta. Yhtiö voi myös ostaa ja myydä kiinteistöjä, osakkeita ja osuuksia sekä harjoittaa vuokraustoimintaa.
Address
Rauhalantie 4-B105
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 584 | 757 | 665 | 929 | 981 |
| Staff expenses | −99 | −126 | −125 | −163 | −172 |
| EBITDA | 80 | 44 | −1 | 28 | 15 |
| Depreciation & amort. | −5 | −13 | −10 | −7 | −5 |
| EBIT | 75 | 31 | −11 | 22 | 10 |
| Net financials | −4 | −3 | −6 | −6 | −13 |
| Profit before tax | 71 | 28 | −17 | 16 | −4 |
| Tax | 4 | 6 | −0 | 1 | 1 |
| Net profit | 67 | 22 | −17 | 15 | −4 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 179 | 316 | 341 | 327 | 335 |
| Equity | 36 | 58 | 41 | 57 | 52 |
| Long-term debt | 31 | 60 | 56 | 51 | 37 |
| Short-term debt | 112 | 198 | 244 | 219 | 245 |
| Total debt | 143 | 258 | 300 | 271 | 282 |
EBITDA margin
1.5%
This company
15.8%
Market median
-91% vs market
20212025
Equity ratio
15.6%
This company
38.2%
Market median
-59% vs market
20212025
Return on equity
-8.6%
This company
18.4%
Market median
-147% vs market
20212025
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20212025
Asset turnover
2.93×
This company
1.12×
Market median
+162% vs market
20212025
Debt / equity
5.42×
This company
0.62×
Market median
-774% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SM Chief Executive Officer | Chief Executive Officer | 2013 |
JK Deputy auditor | Deputy auditor | 2021 |
JJ Audit | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2013 | |
| Board of Directors | 2013 | |
| Board of Directors | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EyeVision Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Santtu Matinpoika Oittinen | Chief Executive Officer | 0 companies |
| Jussi Kalevi Pohjaranta | Deputy auditor | 0 companies |
| Janne Juhani Viitala | Audit | 0 companies |
| Seppo Timo Kuusela | Board of Directors | 0 companies |
| Matti Juhani Oittinen | Board of Directors | 0 companies |
| Samu Oittinen | Board of Directors | 0 companies |